New technology platform helps accelerate vaccine generation

Daniel L. Menichella

Non Executive Director

Dan is President and Chief Executive Officer of Kaleido Biosciences. He is an experienced Chief Executive Officer, having previously been CEO of CureVac. Formerly, Mr. Menichella held the position of Chief Business Officer at several companies, including Bamboo Therapeutics, Applied Genetic Technologies Corporation (AGTC) and Zyngenia, Inc. He earned his Bachelor of Arts from Harvard University and his Master of Business Administration from the University of North Carolina at Chapel Hill.

Back to team

Read more about our pipeline and the diseases we are working to eradicate.

Our Pipeline